The influence of morphine on acid secretion by the isolated rat gastric mucosa

1985 ◽  
Vol 17 (9) ◽  
pp. 855-864 ◽  
Author(s):  
Mai M. Ho ◽  
Clive W. Ogle ◽  
Soter Dai
1976 ◽  
Vol 12 (3) ◽  
pp. 181-191 ◽  
Author(s):  
Rudolf I. Salganik ◽  
Rahmet I. Bersimbaev ◽  
Svetlana V. Argutinskaya ◽  
Elena V. Kiseleva ◽  
Ninel B. Khristolyubova ◽  
...  

2009 ◽  
Vol 87 (5) ◽  
pp. 402-410 ◽  
Author(s):  
Zoran B. Redzic ◽  
Fuad A. Hasan ◽  
Hameed Al-Sarraf

Increased adenosine concentration inhibits gastric acid secretion in rat via adenosine A1 and A2A receptors, whereas achlorhydria suppresses A1 and A2A receptor gene expression. This study aimed to examine the effects of omeprazole-induced achlorhydria on the expression and functional activity of nucleoside transporters in rat gastric mucosa. Wistar rats were treated for either 1 or 3 days with 0.4 mmol/kg omeprazole via gavage; controls were treated with vehicle. The expression of nucleoside transporters at the transcript level was explored by quantitative real-time polymerase chain reaction assays; the functional activity of nucleoside transporters in gastric mucosa was explored by observing [3H]adenosine uptake in vitro. Gastric mucosa expressed rat equilibrative nucleoside transporter (rENT) 1 and 2, and rat concentrative nucleoside transporter (rCNT) 1, 2, and 3 at the transcript level, and the estimated values for the threshold cycles for target amplification (Ct) were 31.5 ± 2, 28.5 ± 2.1, 32.9 ± 2.2, 29.1 ± 2, and 28.9 ± 2.5, respectively (n = 3 or 4). The Ct value for rat β-actin was 21.9 ± 1.8 (n = 4). In vitro uptake of [3H]adenosine by gastric mucosa samples consisted of Na+-dependent and Na+-independent components. One-day omeprazole treatment caused no change in nucleoside transporter mRNA levels or in [3H]adenosine uptake. Three-day omeprazole treatments, however, led to a 12-fold and 17-fold increase in rENT2 and rCNT1 mRNA levels, respectively. Samples taken after 3 days of treatment also took up significantly more [3H]adenosine than did samples from the corresponding control. In conclusion, the possible modification of nucleoside transport activities by changes in intraluminal acidity may have significance as part of a purinergic regulatory feedback mechanism in the control of gastric acid secretion.


Gut ◽  
1998 ◽  
Vol 43 (3) ◽  
pp. 334-341 ◽  
Author(s):  
S Tanaka ◽  
Y Akiba ◽  
J D Kaunitz

Background—Pentagastrin enhances gastric mucosal defence mechanisms against acid and protects the gastric mucosa from experimental injury.Aims—To investigate whether this gastroprotection is mediated by histamine receptors or occurs as a secondary effect of acid secretion stimulation.Methods—The effects of omeprazole (100 μmol/kg), ranitidine (20 mg/kg), and pyrilamine (10 mg/kg) on pentagastrin (80 μg/kg/h) induced gastroprotection against acidified aspirin injury were examined in a luminal pH controlled model. The effects of these compounds on pentagastrin enhanced gastroprotective mechanisms were investigated using intravital microscopy, in which intracellular pH of gastric surface cells (pHi), mucus gel thickness, gastric mucosal blood flow, and acid output were measured simultaneously.Results—Pentagastrin protected rat gastric mucosa from acidified aspirin injury. This gastroprotection was abolished by ranitidine, but not omeprazole or pyrilamine. Pentagastrin induced a hyperaemic response to luminal acid challenge, increased mucus gel thickness, and elevated pHi during acid challenge. Ranitidine reversed these enhanced defence mechanisms, whereas omeprazole and pyrilamine preserved these effects.Conclusions—These data indicate that pentagastrin associated gastroprotection and enhanced defence mechanisms against acid result mainly from activation of histamine H2 receptors, and not as an effect of the stimulation of acid secretion.


Sign in / Sign up

Export Citation Format

Share Document